IE 11 is not supported. For an optimal experience visit our site on another browser.
  • UP NEXT

    FDA Commissioner grilled on when baby formula will return to shelves

    05:01

  • Federal Reserve faces a tough challenge on cooling inflation

    01:46

  • New exhibition at the National Gallery of Art gives viewers global journey through Black history

    01:39

  • Memorial Day vacationers hit with high travel and lodging costs

    01:33

  • Turkey opposes Sweden and Finland’s bid to join

    02:00

  • Nationwide Covid cases are up 55 percent

    01:29

  • Milk banks work to meet demand

    02:09

  • FDA Commissioner grilled on when baby formula will return to shelves

    02:51

  • Secretary of state races in the spotlight as false election theories take root in U.S.

    03:33

  • U.S. Soccer to split World Cup prize money between men’s and women’s teams

    01:38

  • Records show Hunter Biden’s company made millions from joint venture funded by Chinese company

    03:11

  • Russia focuses on Donbas region as Ukraine drives troops back from Kharkiv

    02:01

  • Chilling new details from Buffalo store employee who spoke to suspect the day before he opened fire

    01:31

  • Trump effect tested in close Pennsylvania GOP Senate primary

    02:01

  • Biden invokes Defense Production Act to boost baby formula production

    03:09

  • Amber Heard’s testimony scrutinized during cross-examination in defamation trial

    01:59

  • Pennsylvania Senate candidates make final push on critical primary day

    02:13

  • Ukrainian soldiers in Mariupol’s steel plant surrender, but Russia may label them as a terrorist group 

    01:34

  • Baby giraffe able to walk with the help of human orthopedic group

    01:31

  • Tops closure after Buffalo mass shooting leaves residents without access to groceries

    01:30

Nightly News

World’s best-selling drug costs five times more in U.S. than Europe

02:26

Critics accuse the maker of Humira of exploiting U.S. patent laws to keep competitors’ less expensive versions off the market. The company, AbbVie, says it’s balancing the need to keep the drug affordable to patients with the need to fund new drug development.Feb. 19, 2019

  • UP NEXT

    FDA Commissioner grilled on when baby formula will return to shelves

    05:01

  • Federal Reserve faces a tough challenge on cooling inflation

    01:46

  • New exhibition at the National Gallery of Art gives viewers global journey through Black history

    01:39

  • Memorial Day vacationers hit with high travel and lodging costs

    01:33

  • Turkey opposes Sweden and Finland’s bid to join

    02:00

  • Nationwide Covid cases are up 55 percent

    01:29

Best of NBC News

Play All
Play All